Video Experimental Relacionado
Updated: Jul 12, 2026
09:29
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
15 años después de Chernobyl: nueva evidencia de cáncer de tiroides
Lancet (London, England)
|December 19, 2001
Resumen
El desastre de Chernóbil de 1986 causó un aumento significativo en el cáncer de tiroides entre los niños expuestos a la lluvia radiactiva. Los niños nacidos antes del accidente mostraron una mayor incidencia de cáncer de tiroides después del evento.
Área de la Ciencia:
- Salud Ambiental Salud del medio ambiente.
- La medicina nuclear es una medicina nuclear.
- Oncología Pediátrica Oncología Pediátrica.
Sus antecedentes:
- El accidente de la central nuclear de Chernóbil ocurrió el 26 de abril de 1986, lo que condujo a una contaminación radiactiva generalizada.
- Este estudio examina la incidencia de cáncer de tiroides en niños que residen en un radio de 150 km de Chernóbil, comparando a los nacidos antes y después del accidente.
Videos de Conceptos Relacionados
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...